Paclitaxel Stent Coating Inhibits Neointimal Hyperplasia at 4 Weeks in a Porcine Model of Coronary Restenosis
Top Cited Papers
- 8 May 2001
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 103 (18), 2289-2295
- https://doi.org/10.1161/01.cir.103.18.2289
Abstract
Background—Despite limiting elastic recoil and late vascular remodeling after angioplasty, coronary stents remain vulnerable to restenosis, caused primarily by neointimal hyperplasia. Paclitaxel, a...Keywords
This publication has 12 references indexed in Scilit:
- Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivoJournal of the American College of Cardiology, 2000
- Local drug delivery: Impact of pressure, substance characteristics, and stenting on drug transfer into the arterial wallCatheterization and Cardiovascular Interventions, 1999
- Serial intravascular ultrasound evaluation of remodeling in transplant CAD: influence of disease progressionJournal of the American College of Cardiology, 1998
- Local drug delivery systems and prevention of restenosisCardiovascular Research, 1997
- Paclitaxel (Taxol)New England Journal of Medicine, 1995
- Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat.Journal of Clinical Investigation, 1995
- A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1994
- Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine modelJournal of the American College of Cardiology, 1992
- Taxol stabilizes microtubules in mouse fibroblast cells.Proceedings of the National Academy of Sciences, 1980
- Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifoliaJournal of the American Chemical Society, 1971